Analyte Test Display for Non-Invasive Fluorescence Trend Monitoring

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing analyte testing technologies face challenges such as invasive methods, limited accuracy, and difficulty in separating spectral signals for non-invasive glucose measurement, leading to inaccurate results.

Innovation Solution

A non-invasive analyte testing method using fluorescence spectroscopy to obtain spectral data from different skin areas, combined with a convolutional neural network model for accurate analyte concentration prediction, and a display system for real-time results and historical trends.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Object-affected harmful factors

If Raman spectroscopy is used for non-invasive blood glucose measurement, then non-invasive testing can be implemented, but the device becomes bulky and cannot be portable

Engineering Contradiction:
Improveinvasive testingVSAvoiddevice portability
Core Design Contradiction:
Object-affected harmful factorsVSDevice complexity

Solution Approach 1:

The patent replaces the complex mechanical Raman spectroscopy system with an optical fluorescence detection system. This substitution maintains the non-invasive advantage while significantly reducing device complexity and improving portability, as fluorescence spectroscopy requires simpler optical components and can be implemented in a compact form factor.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent changes the detection parameter from Raman scattering to fluorescence emission. By using fluorescence spectroscopy instead of Raman spectroscopy, the system achieves non-invasive measurement with reduced device complexity. The fluorescence method allows for portable implementation while maintaining measurement capability through appropriate wavelength selection and detection.

Inventive Principle:
Principle #35Parameter changes

2Object-affected harmful factors

If absorption spectroscopy is used for non-invasive glucose testing, then non-invasive measurement can be achieved, but spectral signals of different components are mixed together making it difficult to perform fine separation

Engineering Contradiction:
Improveinvasive testingVSAvoidspectral signal separation accuracy
Core Design Contradiction:
Object-affected harmful factorsVSMeasurement precision

Solution Approach 1:

The patent segments the spectral measurement by selecting specific fluorescence excitation and emission wavelength ranges. Instead of analyzing the entire absorption spectrum where signals are mixed, the system divides the measurement into targeted wavelength bands that selectively capture glucose-related fluorescence signals while minimizing interference from other skin components.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent introduces fluorescence as an intermediary phenomenon between light interaction and glucose detection. By using fluorescence spectroscopy with specific excitation wavelengths, the system converts the complex absorption problem into a selective emission detection problem, where glucose molecules act as fluorescent intermediaries that emit at characteristic wavelengths, enabling better signal separation.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Productivity

If electrochemical method is used for glucose testing, then real-time glucose data can be collected continuously, but invasive sensor implantation is required

Engineering Contradiction:
Improvereal-time data collection frequencyVSAvoidinvasive implantation
Core Design Contradiction:
ProductivityVSObject-affected harmful factors

Solution Approach 1:

The patent replaces the invasive electrochemical sensor implantation with a non-invasive optical fluorescence detection system. This substitution eliminates the harmful invasive implantation while maintaining the capability for continuous real-time monitoring through repeated rapid measurements using portable fluorescence spectroscopy equipment.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent achieves continuous monitoring capability through rapid sequential fluorescence measurements. By using a portable fluorescence spectrometer that can perform measurements quickly and repeatedly, the system maintains continuous tracking of glucose levels without requiring invasive implantation, thus preserving the continuity of useful action while eliminating the harmful invasive aspect.

Inventive Principle:
Principle #20Continuity of useful action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables accurate, non-invasive analyte testing with real-time results and historical trend analysis, reducing discomfort and cost while improving measurement precision.

Implementation Method 1

A non-invasive analyte testing method using fluorescence spectroscopy to obtain spectral data from different skin areas

Methodology Applied
Scientific EffectFluorescence spectroscopy: Fluorescence

Data Source

PatentUS20260020825A1Information display method and slystem in analyte testing, medium, and device
Publication Date: 2026.01.22 SENSURA PTE LTD
  • US20260020825A1 patent drawing
  • US20260020825A1 patent drawing
  • US20260020825A1 patent drawing

AI summary

The present invention provides an information display method and system in analyte testing, a medium, and a device. The method includes: instruction obtaining: obtaining an operation instruction from a user, where the operation instruction includes a testing instruction and a statistical instruction; first displaying: when the operation instruction is the testing instruction, starting a testing process of an analyte testing system and displaying a name of a process being performed on a display, and after the testing process is completed, displaying a test result and a preset reference range of an analyte on the display; and second displaying: when the operation instruction is the statistical instruction, obtaining historical test results from a memory of the analyte testing system, processing the obtained historical test results into a chart form, and displaying a chart on the display.